Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
about
Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR."pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies".Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipientsDifferences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.Sensitivity of the Cytomegalovirus Antigenemia Assay to Diagnose Cytomegalovirus RetinitisHuman cytomegalovirus detection by real-time PCR and pp65-antigen test in hematopoietic stem cell transplant recipients: a challenge in low and middle-income countries.Cytomegalovirus infection in lung transplant recipients.The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.Determination of human cytomegalovirus pp65 antigenemia among renal transplant patients.Quantitative analysis of human herpesvirus-6 and human cytomegalovirus in blood and saliva from patients with acute leukemia.
P2860
Q33591729-A9B6F08A-9FE3-40F4-8A88-2E018916364CQ34387906-B7F2DD45-61E6-4E1B-B9C7-0FFCF4C5DA90Q36788833-0948FE9B-5089-4D43-8A4F-8964AE615475Q37242592-7D11C874-1FA2-4260-B15F-B44250F033E1Q37547835-771CF1CA-20E0-4A64-88AD-72032422D61CQ37726821-F5C2BE35-C234-42F5-9406-0DCDEADEA166Q39226830-90106FEE-47AA-497E-BC4C-C0DDDB798087Q39311630-2DB83F2C-B3C2-47D7-BF43-DC6CD12EBBB7Q41373726-85352C34-45FE-45DE-8F72-E2B35CAC21AFQ42025153-F8E95120-99B7-496A-AAC1-316D96818780Q42197325-CD92BC56-B7F2-4B21-9C0C-AED9C9B8FE30
P2860
Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Relationship between pp65 anti ...... in immunocompromised patients
@ast
Relationship between pp65 anti ...... in immunocompromised patients
@en
Relationship between pp65 anti ...... PCR for Human Cytomegalovirus
@nl
type
label
Relationship between pp65 anti ...... in immunocompromised patients
@ast
Relationship between pp65 anti ...... in immunocompromised patients
@en
Relationship between pp65 anti ...... PCR for Human Cytomegalovirus
@nl
prefLabel
Relationship between pp65 anti ...... in immunocompromised patients
@ast
Relationship between pp65 anti ...... in immunocompromised patients
@en
Relationship between pp65 anti ...... PCR for Human Cytomegalovirus
@nl
P2093
P2860
P356
P1476
Relationship between pp65 anti ...... in immunocompromised patients
@en
P2093
Barbara Valloncini
Carlo Bonfanti
Caterina P Pollara
Francesca Perandin
Nino Manca
P2860
P2888
P356
10.1186/1471-2334-7-138
P577
2007-11-23T00:00:00Z
P5875
P6179
1025257938